BA
ESMC

BlackRock Advisors’s Escalon Medical Corp ESMC Stock Holding History

BlackRock Advisors’s Portfolio ESMC Stock Details ESMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,399
Closed -$1K – 3788
2016
Q3 		$1K Hold
1,399
– – ﹤0.01% 3706
2016
Q2 		$1K Hold
1,399
– – ﹤0.01% 3748
2016
Q1 		$1K Hold
1,399
– – ﹤0.01% 3751
2015
Q4 		$1K Hold
1,399
– – ﹤0.01% 3797
2015
Q3 		$2K Hold
1,399
– – ﹤0.01% 3741
2015
Q2 		$2K Hold
1,399
– – ﹤0.01% 3697
2015
Q1 		$2K Hold
1,399
– – ﹤0.01% 3593
2014
Q4 		$2K Hold
1,399
– – ﹤0.01% 3669
2014
Q3 		$2K Hold
1,399
– – ﹤0.01% 3654
2014
Q2 		$2K Hold
1,399
– – ﹤0.01% 3658
2014
Q1 		$2K Hold
1,399
– – ﹤0.01% 3625
2013
Q4 		$3K Hold
1,399
– – ﹤0.01% 3613
2013
Q3 		$2K Hold
1,399
– – ﹤0.01% 3602
2013
Q2 		$2K Buy
+1,399
New +$1.67K ﹤0.01% 3577

Other funds holding ESMC

WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

BlackRock Advisors's ESMC Position: Q4 2016 in Review

BlackRock Advisors sold out of Escalon Medical Corp (ESMC) in Q4 2016, closing a stake of 1,399 shares — an estimated $1K sold.

BlackRock Advisors first reported a position in ESMC in Q2 2013 and held it in 14 quarters. The position peaked at $3K in Q4 2013. 3 funds tracked by Wall St. Rank hold ESMC as of Q4 2016.

  • BlackRock Advisors reported no remaining Escalon Medical Corp position as of Q4 2016 after selling out during the quarter.
  • BlackRock Advisors sold 1,399 Escalon Medical Corp shares in Q4 2016, an estimated $1K.
  • BlackRock Advisors first reported a position in Escalon Medical Corp in Q2 2013 and held it in 14 quarters.
  • BlackRock Advisors's Escalon Medical Corp position peaked at $3K in Q4 2013.
  • 3 funds tracked by Wall St. Rank held Escalon Medical Corp as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.